Lumicell, Inc.
PrivateLast Round
Series D
Extension
Apr 22, 2025
Est. Valuation
$250M
Total Funding Raised
$202.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumicell, Inc. is a medical device company that develops innovative fluorescence-guided surgical technologies to enable real-time detection and removal of residual cancerous tissue during surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumicell, Inc. Comparables
Compare Lumicell, Inc. with similar companies based on industry and business-model similarity.
Lumicell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Apr 22, 2025 | ||||
| Series D | Jul 11, 2024 | ||||
| Series C | Feb 22, 2024 | ||||
| Series D | Jul 26, 2023 | ||||
| Series D | May 25, 2021 | ||||
Debt | Apr 15, 2020 |
Lumicell, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Furneaux Capital | Series D |
| Kodiak Venture Partners | Series C |
| BlueIO | Series D, Series C |
| Massachusetts Life Sciences Center | Debt |
| Rivas Capital | Series D |
| Kinled Holding | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Fluorescence-guided surgery platform is now a commercially approved Class III medical device.
- Mar 1, 2026
Expanding commercial launch of breast cancer surgery drug/device product.
Lumicell, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumicell, Inc.'s valuation, stock price, and market status.